Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rank in Stocks #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Share Price
$2.37
Last synced: 2025-12-15
Market Cap
$3.99M
Change (1 day)
-5.58%
Change (1 year)
24.74%
Country
US
Trade Qualigen Therapeutics, Inc. (QLGN)

Category

Stock split history for Qualigen Therapeutics, Inc. (QLGN)
Qualigen Therapeutics, Inc. stock (symbol: QLGN) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 16, 2026.
One QLGN share bought prior to Aug 16, 2026 would equal to 0 QLGN shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE